Rights and permissions
About this article
Cite this article
Two lines of debate continue in the beta agonist battle. Inpharma Wkly. 850, 8 (1992). https://doi.org/10.2165/00128413-199208500-00010
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-199208500-00010